Yu LH - Search Results

1

Mechanism of Shashen-Maidong herb pair in treating hepatocellular carcinoma using network pharmacology and experimental validation.

Xie YQ, Yan FN, Yu LH, Yan HW, Kong YX, Yang ZY. Xie YQ, et al. Among authors: yu lh. J Ethnopharmacol. 2025 Jan 30;337(Pt 3):118954. doi: 10.1016/j.jep.2024.118954. Epub 2024 Oct 16. J Ethnopharmacol. 2025. PMID: 39419302 Free article.

2

Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.

Liu X, Li M, Wang X, Dang Z, Yu L, Wang X, Jiang Y, Yang Z. Liu X, et al. Phytomedicine. 2019 Sep;62:152930. doi: 10.1016/j.phymed.2019.152930. Epub 2019 May 11. Phytomedicine. 2019. PMID: 31128485 Clinical Trial.

3

Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B.

Yu L, Liu X, Wang X, Dang Z, Jiang Y, Wang X, Yang Z. Yu L, et al. J Cancer. 2019 Jul 10;10(18):4237-4244. doi: 10.7150/jca.33430. eCollection 2019. J Cancer. 2019. PMID: 31413742 Free PMC article.

4

Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.

Liu X, Hou Y, Wang X, Yu L, Wang X, Jiang L, Yang Z. Liu X, et al. Hepatol Int. 2020 Jul;14(4):567-576. doi: 10.1007/s12072-020-10046-w. Epub 2020 Jun 18. Hepatol Int. 2020. PMID: 32556865 Clinical Trial.

5

Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.

Yu L, Liu X, Jiang Y, Wang X, Wang X, Yang Z. Yu L, et al. Onco Targets Ther. 2020 Nov 6;13:11421-11431. doi: 10.2147/OTT.S275304. eCollection 2020. Onco Targets Ther. 2020. PMID: 33192075 Free PMC article.

6

TIGIT⁺ TIM-3⁺ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma.

Yu L, Liu X, Wang X, Yan F, Wang P, Jiang Y, Du J, Yang Z. Yu L, et al. Oncoimmunology. 2021 Jun 28;10(1):1942673. doi: 10.1080/2162402X.2021.1942673. eCollection 2021. Oncoimmunology. 2021. PMID: 34249476 Free PMC article.

7

Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells.

Yan F, Wang X, Xie Y, Liu X, Yu L, Wang P, Li T, Wang S, Li W, Yang Z. Yan F, et al. Phytomedicine. 2021 Oct;91:153722. doi: 10.1016/j.phymed.2021.153722. Epub 2021 Aug 19. Phytomedicine. 2021. PMID: 34488188 Free article.

8

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia.

Wang X, Liu X, Wang P, Yu L, Yan F, Yan H, Zhou D, Yang Z. Wang X, et al. J Hepatocell Carcinoma. 2021 Oct 21;8:1253-1267. doi: 10.2147/JHC.S330301. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34708007 Free PMC article.

9

Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts.

Yu L, Liu X, Wang X, Zhou D, Yan H, Xie Y, Pu Q, Zhang K, Yang Z. Yu L, et al. Ann Hepatol. 2022 Mar-Apr;27(2):100672. doi: 10.1016/j.aohep.2022.100672. Epub 2022 Jan 20. Ann Hepatol. 2022. PMID: 35065261 Free article.

10

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model.

Yan H, Wang X, Liu X, Wang P, Yu L, Zhou D, Yang Z. Yan H, et al. BMC Cancer. 2022 Feb 18;22(1):185. doi: 10.1186/s12885-022-09293-x. BMC Cancer. 2022. PMID: 35180841 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters